Home

Voitti veljenpoika kokki annkristin heine Netto hammasratas fyysikko

UKB | Oberärzte
UKB | Oberärzte

Annkristin HEINE | Medical Doctor | Professor | University of Bonn -  Medical Center, Bonn | Haematology Oncology | Research profile
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile

Ann-Kristin Sass on LinkedIn: #mixedreality #virtualreality #digitalhealth  #mr #vr #ar
Ann-Kristin Sass on LinkedIn: #mixedreality #virtualreality #digitalhealth #mr #vr #ar

Clinical and immunological effects of mRNA vaccines in malignant diseases |  Molecular Cancer | Full Text
Clinical and immunological effects of mRNA vaccines in malignant diseases | Molecular Cancer | Full Text

UKB NewsRoom | Tückischen Blutkrebs effektiv bekämpfen
UKB NewsRoom | Tückischen Blutkrebs effektiv bekämpfen

Ann SCHMITZ | Heinrich-Heine-Universität Düsseldorf, Düsseldorf | HHU |  Neurochirurgische Klinik | Research profile
Ann SCHMITZ | Heinrich-Heine-Universität Düsseldorf, Düsseldorf | HHU | Neurochirurgische Klinik | Research profile

Annkristin HEINE | Medical Doctor | Professor | University of Bonn -  Medical Center, Bonn | Haematology Oncology | Research profile
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile

Pacritinib protects dendritic cells more efficiently than ruxolitinib -  Experimental Hematology
Pacritinib protects dendritic cells more efficiently than ruxolitinib - Experimental Hematology

Regulation of dectin-1–mediated dendritic cell activation by peroxisome  proliferator–activated receptor-gamma ligand troglitazone - ScienceDirect
Regulation of dectin-1–mediated dendritic cell activation by peroxisome proliferator–activated receptor-gamma ligand troglitazone - ScienceDirect

Loop | Annkristin Heine
Loop | Annkristin Heine

Vemurafenib as bridging therapy of hairy cell leukemia in a Jehovah's  Witness patient | Annals of Hematology
Vemurafenib as bridging therapy of hairy cell leukemia in a Jehovah's Witness patient | Annals of Hematology

Prof. Dr. Annkristin Heine
Prof. Dr. Annkristin Heine

Team | IMMEI
Team | IMMEI

Unter der Leitung von Frau Prof.... - Krebszentrum CIO Bonn | Facebook
Unter der Leitung von Frau Prof.... - Krebszentrum CIO Bonn | Facebook

Researchers release the brakes on the immune | EurekAlert!
Researchers release the brakes on the immune | EurekAlert!

CIO Bonn - Lymphomzentrum
CIO Bonn - Lymphomzentrum

Frontiers | Rapid protection against viral infections by  chemokine-accelerated post-exposure vaccination
Frontiers | Rapid protection against viral infections by chemokine-accelerated post-exposure vaccination

Team | IMMEI
Team | IMMEI

The PI3Kδ inhibitor idelalisib impairs the function of human dendritic  cells | Cancer Immunology, Immunotherapy
The PI3Kδ inhibitor idelalisib impairs the function of human dendritic cells | Cancer Immunology, Immunotherapy

Annkristin HEINE | Medical Doctor | Professor | University of Bonn -  Medical Center, Bonn | Haematology Oncology | Research profile
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile

Universitätsmedizin Bonn heißt Stipendiat:innen willkommen — Medizinische  Fakultät
Universitätsmedizin Bonn heißt Stipendiat:innen willkommen — Medizinische Fakultät

UKB NewsRoom | Annkristin Heine
UKB NewsRoom | Annkristin Heine

Diffuse Myocardial Inflammation in COVID-19 Associated Myocarditis Detected  by Multiparametric Cardiac Magnetic Resonance Imaging | Circulation:  Cardiovascular Imaging
Diffuse Myocardial Inflammation in COVID-19 Associated Myocarditis Detected by Multiparametric Cardiac Magnetic Resonance Imaging | Circulation: Cardiovascular Imaging

Neue Forschungsergebnisse zu Kombinationstherapien bei Hochrisikopatienten  mit COVID-19 – Kabinett Online
Neue Forschungsergebnisse zu Kombinationstherapien bei Hochrisikopatienten mit COVID-19 – Kabinett Online

Auszeichnung für herausragende Krebsforscher - Centrum für Integrierte  Onkologie
Auszeichnung für herausragende Krebsforscher - Centrum für Integrierte Onkologie

Axitinib dose-dependently induces apoptosis in the renal cell carcinoma  cell line A-498, but has no toxic effects on dendritic cells.
Axitinib dose-dependently induces apoptosis in the renal cell carcinoma cell line A-498, but has no toxic effects on dendritic cells.